Blood component-associated acute transfusion reactions in pediatric patients: experience of a tertiary care hospital.


Journal

Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758

Informations de publication

Date de publication:
2024
Historique:
received: 29 12 2023
revised: 18 10 2024
accepted: 16 07 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

The transfusion of blood products is a life-saving clinical practice in patients with bleeding, hemoglobinopathy, and cancer. It was aimed herein to analyze the frequency and types of blood component-related acute transfusion reactions (ATRs) in pediatric patients. This retrospective study was conducted at a tertiary care academic pediatric hospital. During the study period, 30,811 transfusions were administered to 25,448 patients. There were 103 ATRs detected in 81 patients (0.33%; 3.34 reactions per 1000 transfusions, mean age 8.3 ± 5.98 years, 36 females and 45 males). All the reactions were observed within an average of 4 h after the transfusion began. The most common ATRs were allergic reactions (79; 76.6%) and febrile nonhemolytic transfusion reactions (12; 11.6%). All the allergic transfusion reactions occurred within the first hour after the start of the transfusion. Granulocyte concentrates were the blood component associated with the highest ATR rate (2.1%). Within our hospital, pediatric hematology-oncology wards and the stem cell transplantation unit had the most frequent ATR reports; therefore, when transfusions are carried out, increased attention should be given to these units. Educating health staff about the adverse effects of transfusion therapy should increase the awareness and reporting of ATRs in children.

Sections du résumé

Background/aim UNASSIGNED
The transfusion of blood products is a life-saving clinical practice in patients with bleeding, hemoglobinopathy, and cancer. It was aimed herein to analyze the frequency and types of blood component-related acute transfusion reactions (ATRs) in pediatric patients.
Materials and methods UNASSIGNED
This retrospective study was conducted at a tertiary care academic pediatric hospital.
Results UNASSIGNED
During the study period, 30,811 transfusions were administered to 25,448 patients. There were 103 ATRs detected in 81 patients (0.33%; 3.34 reactions per 1000 transfusions, mean age 8.3 ± 5.98 years, 36 females and 45 males). All the reactions were observed within an average of 4 h after the transfusion began. The most common ATRs were allergic reactions (79; 76.6%) and febrile nonhemolytic transfusion reactions (12; 11.6%). All the allergic transfusion reactions occurred within the first hour after the start of the transfusion. Granulocyte concentrates were the blood component associated with the highest ATR rate (2.1%).
Conclusion UNASSIGNED
Within our hospital, pediatric hematology-oncology wards and the stem cell transplantation unit had the most frequent ATR reports; therefore, when transfusions are carried out, increased attention should be given to these units. Educating health staff about the adverse effects of transfusion therapy should increase the awareness and reporting of ATRs in children.

Identifiants

pubmed: 39473757
doi: 10.55730/1300-0144.5869
pii: tjmed-54-05-924
pmc: PMC11518323
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

924-929

Informations de copyright

© TÜBİTAK.

Déclaration de conflit d'intérêts

Conflict of interest: None

Références

North Clin Istanb. 2021 May 24;8(3):261-268
pubmed: 34222807
Front Pediatr. 2021 May 28;9:660297
pubmed: 34123967
Clin Lab Med. 2021 Mar;41(1):51-67
pubmed: 33494885
Indian J Pharmacol. 2015 Jul-Aug;47(4):370-4
pubmed: 26285707
Paediatr Anaesth. 2011 Jan;21(1):14-24
pubmed: 21155923
Transfusion. 2021 May;61(5):1424-1434
pubmed: 33880771
Transfusion. 2015 Mar;55(3):563-70
pubmed: 25145580
Vox Sang. 2018 Feb;113(2):170-176
pubmed: 29243264
Asian J Transfus Sci. 2017 Jul-Dec;11(2):180-187
pubmed: 28970688
Transfus Apher Sci. 2018 Feb;57(1):16-19
pubmed: 29478800
Transfus Apher Sci. 2021 Aug;60(4):103152
pubmed: 33947611
Transfus Med. 2019 Aug;29(4):247-252
pubmed: 30592099
Transfus Med. 2017 Dec;27(6):393-400
pubmed: 29282809
Eur J Pediatr. 2016 Oct;175(10):1361-9
pubmed: 27631588
Transfusion. 2018 Jan;58(1):60-69
pubmed: 28948619
Transfus Clin Biol. 2019 Nov;26(4):329-335
pubmed: 31563446
Transfusion. 2015 Jan;55(1):144-53
pubmed: 25065959
Transfusion. 2018 Apr;58(4):1037-1044
pubmed: 29388216
J Pediatr (Rio J). 2013 Jul-Aug;89(4):400-6
pubmed: 23791024
Transfusion. 2006 Nov;46(11):1899-908
pubmed: 17076844
Cochrane Database Syst Rev. 2016 Apr 29;4:CD005339
pubmed: 27128488
Exp Clin Cardiol. 2006 Summer;11(2):99-101
pubmed: 18651043
Pediatr Blood Cancer. 2020 Dec;67(12):e28734
pubmed: 32975362

Auteurs

Zeliha Güzelküçük (Z)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, Ankara, Turkiye.

Dilek Gürlek Gökçebay (D)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkiye.

Turan Bayhan (T)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.

İkbal Ok Bozkaya (İ)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkiye.

Özlem Arman Bilir (Ö)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkiye.

Vildan Koşan Çulha (V)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, Ankara, Turkiye.

Melek Işik (M)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, Ankara, Turkiye.

Ayca Koca Yozgat (A)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkiye.

Hüsniye Neşe Yarali (HN)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.

Namık Yaşar Özbek (NY)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkiye.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH